Volume 27, Number 1—January 2021
Research
Attribution of Illnesses Transmitted by Food and Water to Comprehensive Transmission Pathways Using Structured Expert Judgment, United States
Table 1
Panel | Pathogen and clinical manifestation target questions | No. experts who provided estimates in initial elicitation | No. experts who revised estimates | No. experts who provided re-elicitation estimates |
---|---|---|---|---|
Panel 1 | Acanthamoeba spp., Balamuthia mandrillaris, Naegleria fowleri | 14 | 4 | Not required |
Panel 2 | Astrovirus, norovirus, rotavirus, sapovirus | 17 | 3 | Not required |
Panel 3 | Brucella spp., Mycobacterium bovis | 16 | 5 | Not required |
Panel 4 | Campylobacter spp., Yersinia enterocolitica | 19 | 5 | Not required |
Panel 5 | Cryptosporidium spp.,Giardia spp. | 21 | 5 | Not required |
Panel 6 | Cyclospora cayetanensis | 21 | 4 | Not required |
Panel 7 | Enterotoxigenic Escherichia coli, other diarrheagenic E. coli, Shigella spp. | 21 | 3 | Not required |
Panel 8 | Hepatitis A virus | 19 | 2 | Not required |
Panel 9 | Legionella spp., nontuberculous Mycobacterium spp. | 9 | 1 | Not required |
Panel 10 | Pseudomonas spp., otitis externa, pneumonia, septicemia | 16 | 7 | 7 |
Panel 11 | Salmonella enterica, nontyphoidal: all serotypes and ages, <5 y of age; Enteritidis, Typhimurium, Newport, I 4,[5],12:i:-, Javiana; other serotypes group 1,* other serotypes group 2† | 14 | 3 | Not required |
Panel 12 | Shiga toxin–producing E. coli O157 and non-O157 | 18 | 4 | Not required |
Panel 13 | Staphylococcus aureus, group A Streptococcus | 19 | 4 | Not required |
Panel 14 | Toxoplasma gondii | 16 | 3 | Not required |
Panel 15 | Vibrio alginolyticus, AGI, non-AGI; V. cholerae, nontoxigenic, AGI, non-AGI; V. parahaemolyticus, AGI, non-AGI; V. vulnificus,‡ non-AGI; Vibrio spp., other, AGI, non-AGI | 15 | 6 | 9 |
*Group 1: serotypes such as Agona, Anatum, Braenderup, Hadar, Heidelberg, Infantis, Oranienburg, Saintpaul, Senftenberg, Thompson. AGI, acute gastrointestinal illness. †Group 2: serotypes such as Bareilly, Gaminara, Give, Mississippi, Norwich, Pomona, Rubislaw, Tennessee, Urbana, Weltevreden. ‡Clinical manifestations of interest for initial elicitation were bacteremia and wound infections.
Page created: October 14, 2020
Page updated: January 27, 2021
Page reviewed: January 27, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.